Cargando…
Acceleration in the DNA methylation age in breast cancer tumours from very young women
Breast cancer in very young women (≤35 years; BCVY) presents more aggressive and complex biological features than their older counterparts (BCO). Our aim was to evaluate methylation differences between BCVY and BCO and their DNA epigenetic age. EPIC and 450k Illumina methylation arrays were used in...
Autores principales: | Oltra, Sara S., Peña-Chilet, Maria, Flower, Kirsty, Martinez, María Teresa, Alonso, Elisa, Burgues, Octavio, Lluch, Ana, Flanagan, James M., Ribas, Gloria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6800453/ https://www.ncbi.nlm.nih.gov/pubmed/31628391 http://dx.doi.org/10.1038/s41598-019-51457-6 |
Ejemplares similares
-
Methylation deregulation of miRNA promoters identifies miR124-2 as a survival biomarker in Breast Cancer in very young women
por: Oltra, Sara S., et al.
Publicado: (2018) -
Breast Cancer in Very Young Patients in a Spanish Cohort: Age as an
Independent Bad Prognostic Indicator
por: Martínez, María Teresa, et al.
Publicado: (2019) -
HDAC5 Inhibitors as a Potential Treatment in Breast Cancer Affecting Very Young Women
por: Oltra, Sara S., et al.
Publicado: (2020) -
MicroRNA profile in very young women with breast cancer
por: Peña-Chilet, Maria, et al.
Publicado: (2014) -
miRNA Expression Analysis: Cell Lines HCC1500 and HCC1937 as Models for Breast Cancer in Young Women and the miR-23a as a Poor Prognostic Biomarker
por: Oltra, Sara S, et al.
Publicado: (2020)